Accelerated drug discovery by rapid candidate drug identification
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference30 articles.
1. Lessons from 60 years of pharmaceutical innovation;Munos;Nat. Rev. Drug Discov.,2009
2. Diagnosing the decline in pharmaceutical R&D efficiency;Scannell;Nat. Rev. Drug Discov.,2012
3. The FDA’s expedited programs and clinical development times for novel therapeutics, 2012-2016;Hwang;JAMA,2017
4. Trends in utilization of FDA expedited drug development and approval programs, 1987–2014: cohort study;Kesselheim;BMJ,2015
5. A study of decrease in R&D spending in the pharmaceutical industry during post-recession;Raghavendra;Int. J. Acad. Res. Part B,2012
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Balancing Molecular Size, Activity, Permeability, and Other Properties: Drug Candidates in the Context of Their Chemical Structure Optimization;Journal of Chemical Information and Modeling;2024-08-13
2. Facilitating the use of the target product profile in academic research: a systematic review;Journal of Translational Medicine;2024-07-29
3. Best practices for machine learning in antibody discovery and development;Drug Discovery Today;2024-07
4. Augmenting DMTA using predictive AI modelling at AstraZeneca;Drug Discovery Today;2024-04
5. ChemMORT: an automatic ADMET optimization platform using deep learning and multi-objective particle swarm optimization;Briefings in Bioinformatics;2024-01-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3